SUBSCRIBE
SUBSCRIBE

BioNTech

NEWS
Policy
Biopharma Update on the Novel Coronavirus: July 22
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 22, 2020.
July 21, 2020
 · 
6 min read
 · 
BioSpace Editorial Staff
Job Trends
Pfizer and BioNTech Ink Deal with UK to Supply 30 Million COVID-19 Vaccine Doses
No financial terms were disclosed, but they are apparently based on delivery time and dose volume.
July 20, 2020
 · 
3 min read
 · 
Mark Terry
Policy
Biopharma Update on the Novel Coronavirus: July 20
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 20, 2020.
July 20, 2020
 · 
2 min read
 · 
BioSpace Editorial Staff
Policy
Biopharma Update on the Novel Coronavirus: July 17
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 17, 2020.
July 16, 2020
 · 
5 min read
 · 
BioSpace Editorial Staff
Drug Development
Biopharma Update on the Novel Coronavirus: July 13
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 13, 2020.
July 13, 2020
 · 
3 min read
 · 
BioSpace Editorial Staff
Policy
BioNTech, Pfizer Snag Fast Track Designation for Two COVID-19 Vaccine Candidates
The designation will provide for an expedited pathway for regulatory review of the preventative medication, which could come later this year.
July 13, 2020
 · 
2 min read
 · 
Alex Keown
Business
BioNTech CEO Believes COVID-19 Vaccine Could be Ready for Approval by December
BioNTech Chief Executive Officer Ugur Sahin predicts the company’s vaccine for COVID-19, which is it co-developing with Pfizer, could be ready for regulatory approval by the end of the year, with hundreds of millions of doses available for immediate distribution.
July 10, 2020
 · 
3 min read
 · 
Alex Keown
Policy
Biopharma Update on the Novel Coronavirus: July 10
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for July 10, 2020.
July 9, 2020
 · 
4 min read
 · 
BioSpace Editorial Staff
Drug Development
Clinical Catch-Up: June 29-July 3
Heading into the 4th of July holiday in the U.S., there was still a fair amount of clinical trial news last week. Here’s a look.
July 2, 2020
 · 
7 min read
 · 
Mark Terry
Load More
JOBS
IN THE PRESS
Press Releases
BioNTech Announces Third Quarter 2025 Financial Results and Corporate Update
November 4, 2025
 · 
29 min read
Press Releases
BioNTech to Host Innovation Series R&D Day on November 11, 2025
October 29, 2025
 · 
1 min read
Press Releases
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
October 28, 2025
 · 
2 min read
Press Releases
BioNTech Commences Public Exchange Offer for All Outstanding Shares of CureVac N.V.
October 22, 2025
 · 
18 min read
Press Releases
BioNTech to Host Second AI Day as an Edition of Its Innovation Series on October 1, 2025
September 23, 2025
 · 
1 min read
Press Releases
OncoC4 to Present Global Pivotal Phase 3 Trial Design for Next-Generation CTLA-4 Antibody Gotistobart Monotherapy Being Co-Developed with BioNTech in NSCLC at the IASLC 2025 World Conference on Lung Cancer
September 9, 2025
 · 
4 min read
Press Releases
Pfizer and BioNTech Announce Topline Data Demonstrating Robust Immune Response With Their LP.8.1-Adapted COVID-19 Vaccine 2025-2026 Formula
September 9, 2025
 · 
19 min read
Press Releases
First Disclosure of Global Interim Phase 2 Data for BioNTech and Bristol Myers Squibb PD-L1xVEGF-A Bispecific Antibody Pumitamig (BNT327/BMS986545) in Patients with Extensive-Stage Small Cell Lung Cancer Shows Encouraging Antitumor Activity
September 9, 2025
 · 
15 min read
Press Releases
Pfizer and BioNTech’s COMIRNATY® Receives U.S. FDA Approval for Adults 65 and Older and Individuals Ages 5 through 64 at Increased Risk for Severe COVID-19
August 28, 2025
 · 
19 min read
Press Releases
Pfizer Canada and BioNTech Receive Health Canada Approval of LP.8.1 Variant Adapted COVID-19 Vaccine
August 18, 2025
 · 
3 min read
Load More